Navigation Links
AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
Date:10/22/2007

BENICIA, Calif., Oct. 22 /PRNewswire/ -- AcroMetrix, the leading provider of quality control standards for clinical diagnostic and blood testing laboratories, announced that they have enhanced their OptiQuant HIV-1 Quantification Panel to be the first to utilize an EDTA-based normal human plasma matrix. This product is for Research Use Only, not for use in diagnostic procedures.

This new matrix, called OptiMatrix, allows the OptiQuant HIV-1 panel to most closely mimic a patient sample. The commutability of the OptiQuant HIV panel ensures accurate comparison and compatibility between a wide variety of testing platforms globally. As a further improvement, AcroMetrix panel members are the first to be directly traceable to International Units per milliliter (IU/mL) to facilitate global quality through ISO standards.

"The OptiQuant HIV-1 Quantification Panel represents our commitment to standardization in diagnostics," said Michael J. Eck, President and CEO. "The new OptiQuant panel is the first HIV validation panel available to be traceable to the WHO standard, in a truly commutable matrix."

This new OptiQuant HIV Panel fully complies with the ISO 17511:2003 (In vitro diagnostic medical devices -- Measurement of quantities in biological samples -- Metrological traceability of values assigned to calibrators and control materials) standard. Through the ISO 17511 standard, AcroMetrix aims to facilitate a uniform global quality control network by producing consistent and traceable universal standards.

"Our goal is to standardize diagnostic testing so that a patient can receive a truly comparable test result regardless of the doctor or laboratory they choose to visit," said Mr. Eck, "The new OptiQuant HIV panel is a step in that direction for HIV viral load testing."

About AcroMetrix

AcroMetrix, with facilities in Benicia, California and Alkmaar, the Netherlands, provides a comprehensive line of molecular and serological diagnostic
'/>"/>

SOURCE AcroMetrix
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Insmed Releases Positive Results from Iplex Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
2. State of Diabetes in Pittsburgh: Pittsburgh Business Group on Health Releases Report
3. Analyzers Offer Point-of-Care Lipid Panels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...wswire-FirstCall/ -- , - Not for UK Journal... Products for Human Use (CHMP) today,announced it...el(R),(etanercept) as a treatment for children ag...laque psoriasis. If approved by the European,Comm...Enbrel will become the,first biologic treatment i...
(Date:11/20/2008)...Nov. 20 GlaxoSmithKline (...es Food and Drug Administration (FDA) granted acce... the treatment of thrombocytopenia in patients wit...pura (ITP) who have had an insufficient response t... The approval is a significant milestone for PROMA...
(Date:11/20/2008)...FirstCall/ -- Duska Therapeutics,Inc., (OTC Bull...mitted its,pivotal Phase 3 ATPace clinical trial ...ssment (SPA) procedure with the U.S. Food and Drug...ng an agreement with the FDA, Duska intends to ini...o-controlled and randomized Phase 3,clinical tria...
(Date:11/19/2008)... Posit Science Corporation,researcher, Dan Tinker...ce,Annual Conference in Washington, DC this week ...by Boomers. The computerized brain plasticity-bas...ises that target auditory and,language systems. ...mprovements in cognition by improving speed and ac...
Breaking Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Location location location important for genes too 4646 1Location location location important for genes too 4646 2VentriPoint Diagnostics Files Management Discussion and Analysis Unaudited Financial Results for 2Q 2008 7393 1VentriPoint Diagnostics Files Management Discussion and Analysis Unaudited Financial Results for 2Q 2008 7393 2Carilion Clinic Invests in Sight Saving Technology to Improve Patient Care 3A Carilion Clinic Teams Up with Retasure 7389 1Carilion Clinic Invests in Sight Saving Technology to Improve Patient Care 3A Carilion Clinic Teams Up with Retasure 7389 2Dr Joel Aronowitz Specialist in Los Angeles Body Lift Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 25871 1Dr Joel Aronowitz Specialist in Los Angeles Body Lift Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 25871 2Dr Joel Aronowitz Specialist in Los Angeles Body Lift Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 25871 3Dr Joel Aronowitz Specialist in Los Angeles Body Lift Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 25871 4
...2007 /PRNewswire/ -- Addex Pharmaceuticals,announc...proof of,concept trial with its lead compound ADX1... its primary objective, the absence of,pain at 2 h...and,also showed trends towards improvement in pain...ther time points. ADX10059 has,already recently de...
...WIRE)--Apr 19, 2007 - Gilead Sciences, Inc.,(Nasda...ase III,AIR-CF2 study evaluating aztreonam lysine ...stic fibrosis (CF) who have,pulmonary Pseudomonas ... treatment course of aztreonam lysine significantl...nous (IV) antibiotics versus,placebo. All patients...
Other Medicine Technology:Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 2Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 3Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7
(Date:11/21/2008)... Nov. 21 New research a...a smokeless, spitless tobacco product aimed at you... found that RJ Reynolds, Camel Snus - touted as a ...tains surprisingly high levels of nicotine. , ...other snuff products," said Bruce Adkins of the st...
(Date:11/21/2008)...J., Nov. 21 Today, presc...ervention in treating 88 percent of patients suffe...ans treated for a chronic condition account for 96...percent of all medical costs. A proprietary new p...Health Solutions, Inc. (NYSE: MHS ) significantl...
(Date:11/21/2008)...RNewswire/ -- In a statewide survey, 33 physicians...or Surgery at Presbyterian Hospital of Dallas were...ting of " Super Doctors ." , , Each year, t...fessional Media, Inc. to survey more than 38,000 m...ask, "If you needed medical care, which doctor wou...
(Date:11/21/2008)...bacco use is more prevalent and smoking cessation ...yperactivity Disorder (A.D.H.D.) In a study of sm...ptoms, those who exhibited elevated hyperactivity ...ed lower quit rates after 8 weeks than those with ...D.H.D. symptoms. The study, now available online ...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2
...l technology to rapidly screen thousands of drugs ... health threats// in the United States — diabetes ...ular biology and pharmacology at Washington Univer...nd Thomas Baranski, M.D., Ph.D., professor of medi...
...al synapses, microanatomical structures similar to...the Board of Governors' Gene Therapeutics Research...firmed the existence of anatomical structures that... a T cell and its target, an antigen-presenting br...
...interest of researchers from Auckland University, ...ma in humans, after the trials// on rats proved su...rd to having a few volunteers on board to investig...served an increase in allergies like asthma with c...
...ct surgery is higher in patients who have taken al... prostate.// According to the 3 medical associati...erican Society of Cataract and Refractive Surgery ..., mentioning the use of drugs like Flomax (tamsulo...
Other Medicine News:Health News:New Company Will Seek Drugs Against Diabetes and Cancer 2Health News:New Company Will Seek Drugs Against Diabetes and Cancer 3Health News:Alpha-blockers call for modification in cataract surgery 2Health News:Alpha-blockers call for modification in cataract surgery 3
...ons stand alone. It can also be installed as part ...a management system which can be used in ophthalmi...us, retinal surgeries are supported through the mo...per charts. They are supported on tablet PC techno...
...n a powerful, easy-to-use medical practice design ...and business requirements and situations of an oph...rovide patient care assistance as well as ensure d... for Eye's simple "point and click" or touch scree...
...ion to assist you in managing your optometric prac...hrough the creative use of technology. No more nee...waiting to see the doctor. No more wasting time se... handwriting on all paperwork. Give your administr...
...c Medical Office (EMO) for the Optometry specialis...n addition to retrieving and storing your charts e...e patient office flow including documentation of p... billing information. ChartLogic also gives you da...
Medicine Products: